Stocksigma LogoStocksigma Logo

Norris Medicines Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 65.7 (-67.2% YoY | -29.0% QoQ) ■ EBITDA: -22.6 (+53.7% YoY | +19.8% QoQ) ■ EBITDA Margin (%): -34.5 (-1005 bps YoY | -398 bps QoQ) ■ PAT: -36.2

Norris Medicines Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Norris Medicines Ltd · Outcome · 14 Nov 2026, 11:32 pm

Norris Medicines Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 65.7 (-67.2% YoY | -29.0% QoQ) ■ EBITDA: -22.6 (+53.7% YoY | +19.8% QoQ) ■ EBITDA Margin (%): -34.5 (-1005 bps YoY | -398 bps QoQ) ■ PAT: -36.2 (+49.6% YoY | +8.7% QoQ) ■ EPS (INR): -0.36 (+50.0% YoY | +10.0% QoQ)

Original exchange filing (PDF)

More announcements from Norris Medicines Ltd

All Norris Medicines Ltd announcements